Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)

This document is a response to comments regarding the Implantable Continuous Glucose Monitors (I-CGM) LCD and records that National Government Services solicited public and provider comments. It notes the official notice period begins 2020-10-15 and the final determination becomes effective 2020-12-01; no clinical coverage criteria, indications, limitations, or frequency rules are provided in this document.

"National Government Services solicited comments from the provider community and members of the public as part of LCD development for Implantable Continuous Glucose Monitors (I-CGM)."

Sign up to see full coverage criteria, indications, and limitations.